Minnesota Commissioner of Health Dr. Ed Ehlinger decides to add intractable pain as a qualifying condition for the Minnesota medical cannabis program.Read More
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a rapidly progressive,…Read More
Medical Cannabis User Feels Vindicated After Charges Dropped By Chris Joseph | Published…Read More
By Charles Billi | Published in WTSP.com You may not know the name Cathy…Read More
Florida Medical Marijuana Patient, Cathy Jordan, Explains How Cannabis Keeps Her Alive Having survived…Read More
Maria Mills Greenfield March 10, 2010 – At the state capitol in Tallahassee, Rep….Read More
Tod Mikuriya, MD, did not live to see it, but his dream of investigating the medical potential of compounds in the cannabis plant other than THC is now within the grasp of his successors.
The Society of Cannabis Clinicians, the group Mikuriya founded in 1999, has drafted a “Strain Evaluation Survey” to collect data from patients who medicate with cannabis in which cannabidiol (CBD) is predominant
CBD-rich cannabis will be available at California and Colorado dispensaries by late summer —and soon thereafter, inevitably, in other states where patients can legally use cannabis as medicine.
Twelve strains rich in cannabidiol (CBD) have been identified in the year and a half since an analytic chemistry lab began testing cannabis samples provided by California dispensaries, growers, and edible makers. Buds from five of these strains have been available intermittently at Harborside Health Center in Oakland. Herbal Solutions in Long Beach also has provided CBD-rich cannabis to patients.
Eight of the CBD-rich strains are currently being grown out. The others cannot be reproduced because the growers hadn’t saved or couldn’t regain access to the genetic material that yielded their buds of interest.Read More